| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DIABETES.55.03.06.DB05-1417 |
| P8608 | Fatcat ID | release_sj5i335ly5fwhhp2boyh6mpb5m |
| P3181 | OpenCitations bibliographic resource ID | 454811 |
| P698 | PubMed publication ID | 16505242 |
| P5875 | ResearchGate publication ID | 7272917 |
| P2093 | author name string | Ishwarlal Jialal | |
| Sridevi Devaraj | |||
| Nicole Glaser | |||
| Eric Miguelino | |||
| Janice Wang-Polagruto | |||
| Steve Griffen | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| inflammation | Q101991 | ||
| patient | Q181600 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | 774-9 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes | |
| P478 | volume | 55 |
| Q55135310 | 9- and 13-HODE regulate fatty acid binding protein-4 in human macrophages, but does not involve HODE/GPR132 axis in PPAR-γ regulation of FABP4. |
| Q36697677 | A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction |
| Q39095729 | A plasma diagnostic model of human T-cell leukemia virus-1 associated myelopathy |
| Q34785213 | Aberrant Pregnancy Adaptations in the Peripheral Immune Response in Type 1 Diabetes: A Rat Model |
| Q33768652 | Acute suppression of circulating sCD40L during hyperglycemia and euglycemic-hyperinsulinemia in healthy young males |
| Q37072778 | Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells |
| Q36506979 | Alterations in monocyte CD16 in association with diabetes complications. |
| Q34193612 | Alterations of the salivary secretory peptidome profile in children affected by type 1 diabetes |
| Q36471384 | Antisense to protein kinase C-alpha and p47phox attenuates the pro-inflammatory effects of human C-reactive protein in macrophages of biobreeding diabetic rats |
| Q38451253 | Are reactive oxygen species still the basis for diabetic complications? |
| Q38001051 | Arjunolic acid: beneficial role in type 1 diabetes and its associated organ pathophysiology |
| Q38055151 | Aspects of inflammation and oxidative stress in pediatric obesity and type 1 diabetes: an overview of ten years of studies |
| Q50220864 | Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats |
| Q36411246 | C-Reactive protein and progression of vision loss in retinitis pigmentosa |
| Q37815562 | C-peptide and long-term complications of diabetes |
| Q84986264 | C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia |
| Q41969861 | Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo |
| Q37172727 | Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies |
| Q36551840 | Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function. |
| Q37181767 | Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes |
| Q92196955 | Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions |
| Q33937994 | Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications |
| Q34350546 | Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature |
| Q33693974 | Diabetes is a proinflammatory state: a translational perspective |
| Q35849515 | Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. |
| Q28072462 | Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive? |
| Q42964142 | Diabetes-accelerated atherosclerosis and inflammation |
| Q36199128 | Diabetic vascular disease and the potential role of macrophage glucose metabolism |
| Q37131598 | Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia |
| Q36906389 | Distinct monocyte gene-expression profiles in autoimmune diabetes |
| Q34015684 | Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis |
| Q35428861 | Effect of hyperketonemia (Acetoacetate) on nuclear factor-κB and p38 mitogen-activated protein kinase activation mediated intercellular adhesion molecule 1 upregulation in endothelial cells |
| Q38189119 | Effector and regulatory T cell subsets in diabetes-associated inflammation. Is there a connection with ST2/IL-33 axis? Perspective. |
| Q34240279 | Elevated levels of serum IL-12 and IL-18 are associated with lower frequencies of CD4(+)CD25 (high)FOXP3 (+) regulatory t cells in young patients with type 1 diabetes |
| Q38001402 | Endothelial progenitor cells in diabetes mellitus. |
| Q38845518 | Epigenetic Changes in Diabetes and Cardiovascular Risk. |
| Q36752495 | Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes |
| Q51042250 | Epigenetics in type 1 diabetes: TNFa gene promoter methylation status in Chilean patients with type 1 diabetes mellitus. |
| Q37200532 | Epigenetics of diabetic complications |
| Q37218448 | Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications |
| Q38125149 | Exercise and type 1 diabetes (T1DM). |
| Q36516880 | Fisetin inhibits hyperglycemia-induced proinflammatory cytokine production by epigenetic mechanisms |
| Q42585205 | Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD). |
| Q37134825 | Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice |
| Q79812000 | High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes |
| Q37176774 | High glucose induces IL-1beta expression in human monocytes: mechanistic insights |
| Q36943779 | High glucose induces toll-like receptor expression in human monocytes: mechanism of activation |
| Q37858852 | High glucose up-regulates lipopolysaccharide-stimulated inflammatory cytokine production via c-jun N-terminal kinase in the monocytic cell line THP-1. |
| Q39329719 | High levels of glucose induce "metabolic memory" in cardiomyocyte via epigenetic histone H3 lysine 9 methylation |
| Q36113661 | Human C-reactive protein accentuates macrophage activity in biobreeding diabetic rats |
| Q36312635 | Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy |
| Q34950714 | Hyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy |
| Q35159369 | Hyperketonemia increases monocyte adhesion to endothelial cells and is mediated by LFA-1 expression in monocytes and ICAM-1 expression in endothelial cells |
| Q64960610 | Icariin prevents cytokine-induced β-cell death by inhibiting NF-κB signaling. |
| Q36701499 | Impact of diabetes on cardiovascular disease: an update |
| Q35860851 | Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes |
| Q36088408 | Increased Expression of Monocyte CD11b (Mac-1) in Overweight Recent-Onset Type 1 Diabetic Children |
| Q37399738 | Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus |
| Q37259921 | Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes |
| Q37408117 | Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway |
| Q34981029 | Increased systemic Th17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosis |
| Q36459935 | Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state |
| Q37002385 | Inflammation and neuropeptides: the connection in diabetic wound healing |
| Q27331780 | Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivo |
| Q35251581 | Inflammatory cytokine profiles during exercise in obese, diabetic, and healthy children |
| Q54976817 | Inhibition of miR-25 aggravates diabetic peripheral neuropathy. |
| Q33753663 | Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data |
| Q34448684 | Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy |
| Q35853885 | Interleukin-6 (IL-6) mediated the increased contraction of distal colon in streptozotocin-induced diabetes in rats via IL-6 receptor pathway |
| Q55023430 | Intermittent High Glucose Exacerbates A-FABP Activation and Inflammatory Response through TLR4-JNK Signaling in THP-1 Cells. |
| Q35143026 | Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy |
| Q57182351 | Linking diabetes and atherosclerosis |
| Q35140825 | Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes |
| Q53749188 | Long-term study of the association of adipokines and glucose variability with diabetic complications. |
| Q35769521 | Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC Cohort |
| Q39016043 | Luteolin inhibits hyperglycemia-induced proinflammatory cytokine production and its epigenetic mechanism in human monocytes |
| Q37165322 | Lymphoblastoid Cell Lines as a Tool to Study Inter-Individual Differences in the Response to Glucose |
| Q34131197 | Macrophages and β-cells are responsible for CXCR2-mediated neutrophil infiltration of the pancreas during autoimmune diabetes |
| Q37146727 | MicroRNAs: potential mediators and biomarkers of diabetic complications. |
| Q38916635 | Microglia and Monocyte-Derived Macrophages in Stroke |
| Q51730496 | Modulation of diabetes-related liver injury by the HMGB1/TLR4 inflammatory pathway. |
| Q39392202 | Monocyte count-to-high-density lipoprotein-cholesterol ratio is associated with abdominal aortic aneurysm size |
| Q33930285 | Monocyte gene-expression profiles associated with childhood-onset type 1 diabetes and disease risk: a study of identical twins |
| Q89967822 | Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes |
| Q37405753 | Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells |
| Q36063184 | Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes |
| Q89619566 | Neuroprotective Effect of Resveratrol via Activation of Sirt1 Signaling in a Rat Model of Combined Diabetes and Alzheimer's Disease |
| Q34572620 | Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. |
| Q47773228 | Oral delivery of staphylococcal nuclease by Lactococcus lactis prevents type 1 diabetes mellitus in NOD mice |
| Q45905944 | Paeoniflorin attenuates incipient diabetic nephropathy in streptozotocin-induced mice by the suppression of the Toll-like receptor-2 signaling pathway. |
| Q29615424 | Peroxynitrite: biochemistry, pathophysiology and development of therapeutics |
| Q35161591 | Potential role of IL-17-producing iNKT cells in type 1 diabetes |
| Q61478347 | Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4 |
| Q37224999 | Proinflammatory effects of advanced lipoxidation end products in monocytes |
| Q54485624 | Proinflammatory effects of malondialdehyde in lymphocytes. |
| Q33602274 | Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot |
| Q36942224 | Prospective association between inflammatory markers and progression of coronary artery calcification in adults with and without type 1 diabetes |
| Q37563966 | Reappraising the stereotypes of diabetes in the modern diabetogenic environment |
| Q30525793 | Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment |
| Q46284091 | Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes |
| Q33656668 | Resting and exercise-induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the previous 3 days |
| Q34984962 | Restoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin |
| Q37237216 | Risk factor correlates of platelet and leukocyte markers assessed by flow cytometry in a population-based sample |
| Q36906245 | Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications |
| Q38059670 | Role of epigenetic mechanisms in the vascular complications of diabetes. |
| Q46975807 | S-adenosylmethionine attenuates oxidative liver injury in micropigs fed ethanol with a folate-deficient diet |
| Q34013080 | Salivary peptidome in type 1 diabetes mellitus. |
| Q38236202 | Significance of CXCL12 in type 2 diabetes mellitus and its associated complications |
| Q38797855 | Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis. |
| Q26775403 | Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications |
| Q35772650 | Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection |
| Q34629092 | Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. |
| Q63915339 | TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice |
| Q37330560 | TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells |
| Q27010594 | Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation? |
| Q46302966 | Taurine counteracts the neurotoxic effects of streptozotocin-induced diabetes in rats. |
| Q64897993 | The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review. |
| Q83401137 | The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications |
| Q37806610 | The multiple faces of autoimmune-mediated bone loss |
| Q28285897 | The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time |
| Q24609124 | The role of epigenetics in the pathology of diabetic complications |
| Q30413135 | The role of macrophage polarization in infectious and inflammatory diseases |
| Q39321884 | The roles of bile acids and applications of microencapsulation technology in treating Type 1 diabetes mellitus. |
| Q42132761 | Tissue plasminogen activator treatment of stroke in type-1 diabetes rats |
| Q47381207 | Tonicity-Responsive Enhancer-Binding Protein Mediates Hyperglycemia-Induced Inflammation and Vascular and Renal Injury. |
| Q36883079 | Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. |
| Q37172723 | Type 1 diabetes, hyperglycaemia, and the heart |
| Q35881759 | Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture |
| Q33363965 | Where genes meet environment-integrating the role of gut luminal contents, immunity and pancreas in type 1 diabetes |
Search more.